PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Fertil Steril. Author manuscript; available in PMC 2011 May 1.
Published in final edited form as:
PMCID: PMC2860000
NIHMSID: NIHMS147074

Patients’ report on how endometriosis affects health, work, and daily life

NARRATIVE ABSTRACT

The objective of this study was to assess the burden of endometriosis by obtaining Patient Reported Outcome (PRO) data describing the experience of living with this disease. Survey data from one hundred and seven women with self-reported, surgically diagnosed endometriosis showed that living with this disease may be characterized by physical limitations that disrupt health, work and daily life.

Keywords: Endometriosis, patient-reported outcomes, pelvic pain, menstrual pain, infertility, work performance

Endometriosis, the growth of endometrial tissue (glands and stroma) outside of the uterine cavity, causes intractable pelvic pain, dysmenorrhea, dyspareunia, and infertility (1). It is estimated that up to 80% of women with dysmenorrhea and up to 40% of infertile women have endometriosis (2,3). The pelvic pain can be cyclic or chronic, and is often incapacitating (4). Qualitative studies have shown that endometriosis symptoms have a substantial impact on the physical, emotional, and social wellbeing of patients, who are affected during the most productive years of their lives (5-12).

The high rates of hospital admissions, surgical procedures, and incidence of comorbid conditions make endometriosis a more costly public health problem than commonly known medical conditions in women such as migraine and Crohn’s disease (13-17). The yearly total (direct plus indirect) cost of endometriosis has been estimated at €30 billion in Europe and $22 billion in the US, and direct costs have increased steadily (13,18-20). Despite the fact that endometriosis is a common gynecologic disorder that poses a significant economic impact to health care systems around the world, only a few Patient-Reported Outcome (PRO) studies have been conducted to quantify its impact (21-24). These studies concluded that endometriosis impairs health related quality of life (HRQoL), specifically in areas related to physical, psychological, and social function.

The aim of this study was to determine the burden of disease by obtaining PRO data describing the experience of living with this painful disease in patients from Puerto Rico, where a patient registry exists since 2001. This study examined in particular the impact that endometriosis-related and/or coexisting symptoms had on the ability of patients both to participate in normal, daily life activities and to be able to work or be successful at work. The main health-related concerns affecting normal life activities of endometriosis patients were identified. The study protocol and survey was approved by the Ponce School of Medicine (PSM) Institutional Review Board (IRB).

Since 2001, the Endometriosis Research Program (ERP) at PSM has been obtaining demographic and clinical information from patients with endometriosis, women with endometriosis symptoms, and controls recruited by Ob-Gyn referrals (29%), a patient support group (12%), and media announcements (web page, newspapers, magazines, radio, and TV; 59%). The ERP registry consists of 2,060 entries, of which 715 are patients reporting a surgical diagnosis of endometriosis, 246 are controls with no endometriosis, and the remaining are women who may have endometriosis. Subjects in this patient registry come from all regions of the island; however, they do not necessarily accurately represent the female population of Puerto Rico. An anonymous PRO instrument was distributed randomly via postal mail (n=200) or electronically to all the e-mail addresses in the ERP (n=361).

The questionnaire included questions in the following categories: Demographic information and gynecological profile; Symptoms, diagnosis, and treatments; and Impact on daily life activities and work performance. Only women reporting having been diagnosed by laparoscopy or laparotomy were included in the analyses. The diagnosis of endometriosis was supported by questions regarding the surgical procedure, surgeon, and rAFS endometriosis stage (25,26). Symptoms were reported using a 36-item checklist. Dysmenorrhea was defined as “always or almost always suffering from pelvic pain during menses” and dyspareunia as “always or almost always suffering from pain during intercourse”. Painful symptoms were categorized as menstrual pain (MP; pelvic pain felt “only during menses”), ovulatory pain (OP; “during ovulation”), and non-menstrual pain (NP; “throughout the month”). When asked if the pain interfered with daily life activities, patients who answered “yes” were categorized as suffering from “incapacitating pain” (IP). Infertility status was determined by asking patient’s perceptions regarding difficulty getting pregnant and by taking an obstetric history. Lifetime history of surgical procedures and treatments were also surveyed. A 9-item checklist asked which life activities they felt were affected by pain. Impact of symptoms on work performance were documented in four dimensions: i) quality of work, ii) physical disability, iii) absenteeism, and iv) professional growth.

A total of 108 patients answered the survey, for a response rate of 24%. One patient was excluded because she did not report a surgical diagnosis. The patients surveyed represent 15% of the total number of patients in the ERP registry. Patient characteristics were described and frequency, means and standard deviation (SD) were calculated. Demographic, gynecologic and clinical characteristics are summarized in Table 1. There were no differences in demographics (e.g., age, marital status, education) between respondents of the electronic versus the mailed questionnaires.

TABLE 1
Demographics, gynecological and clinical profile of women with self-reported surgically-diagnosed endometriosis in Puerto Rico

Logistic regression analysis was conducted to determine which endometriosis-related and/or coexisting symptoms were more likely to affect daily life activities and work performance of patients. The following dependent variables were studied, controlling for age as confounding factor: household chores, work, social activities, sexual relationships, studies, childcare, sleeping, exercise, and appetite. Independent variables included in the model were those symptoms found to be significantly associated with impairment of daily life activities by univariate analysis (e.g., MP, IP, abdominal pain, depression, dyspareunia, nausea). All tests were two-tailed, and alpha level was set at 0.05 for significance. Statistical analyses were done using SPSS 15.0 (SPSS Inc., Chicago, IL).

All patients in this study were symptomatic and 72% reported having ≥8 endometriosis-related or coexisting symptoms, being dysmenorrhea, incapacitating pain, and dyspareunia the most common (Table 1). Symptoms started during adolescence (11-19 y/o) for the majority of these patients. The mean delay in diagnosis in these subjects was 8.9 years (SD±7.9). This study thus confirms a worrisome trend and worldwide public health problem: patients with endometriosis endure symptoms for years without being diagnosed (8-12, 27-29). One important factor in this delay is the fact that, as observed by others and us (Table 1), many patients consulted with five or more physicians before being diagnosed (29,30). Lack of disease awareness is also an important issue. In our study, 65% of patients had never suspected having endometriosis and had never heard of the disease before surgery. Those who had heard about the condition did so through the media (n =15, 14%) or a friend/family member (n=9, 8%). Therefore, our study adds evidence to support the need for more aggressive awareness campaigns to help spread the message that painful menstruation is not normal.

Most patients characterized their pain as non-menstrual (NP) and reported that pain interfered with their daily life activities (IP). Disease severity was moderate to severe for approximately 70% (n=74). Interestingly, 40% (n=43) of the respondents had a self-reported family history of endometriosis. This rate of family history is higher than what has been reported in other published studies of patients from Puerto Rico (20%) (31), Brazil (8.9%) (32), Japan (8.8%) (33), and the US (8.1%) (34). The majority (71%; n=76) of patients in this study have tried to get pregnant, and 90% of them (n=68/76) reported having problems conceiving. However, only 48% (n=33/68) sought infertility treatments, including super-ovulation (37%), artificial insemination (13%), surgery (3%), or a combination thereof (22%). Of those reporting problems conceiving, 65% (n=44/68) did conceive. Seven out of 10 participants were nulliparous. Hysterectomy was reported by 17% (n=18) of respondents (age range: 31-46 y/o).

Almost all (96%) of the participants had private medical insurance, which generally covered surgical procedures (n=117/126, 93%), but not medical treatments (n=108/214; 50%). Patients reported a total of 248 surgeries (average of 2.3 procedures per patient). The most common treatments for endometriosis reported were GnRH agonists (n=62, 57.9%) and oral contraceptives (OC) (n=43, 40.2%). Reported restrictions on coverage included limitations to a certain number of procedures and pre-set limits in total health-care costs. Commonly, study subjects reported that full coverage of endometriosis-related treatments (e.g., GnRH agonists) and procedures (e.g., laparoscopy) was denied since they were wrongly considered as being infertility treatments. In Puerto Rico, health insurance companies do not usually cover contraceptive drugs (even when prescribed as a treatment for endometriosis) or treatments/procedures related to infertility.

Patients in this study commonly reported that endometriosis-related and co-existing symptoms disrupted all aspects of their daily lives. Many felt physical limitations to conducting day-to-day tasks, such as household chores (n=84, 79%), sexual relationships (n=76, 71%), work (n=71, 66%), appetite (n=58, 54%), exercise (n=60, 56%), sleeping (n=58, 54%), and social activities (n=51, 48%). Of those women who had children, 45% (n=15/33) reported that childcare-related activities were affected. This study supports previous findings showing that patients with endometriosis commonly endure both painful symptoms and infertility, both of which could negatively affect the quality of life and mental health of the affected women at rates that are higher than those reported by healthy women or women with other gynecological disorders (6-12,35,36).

It is to be expected that a painful, chronic disease such as endometriosis would also have a substantial negative impact on work performance, as has been shown for other health problems (37-39). For endometriosis, there is paucity of data in that regard, although qualitative studies document patient-reported negative experiences at work (5). The majority of patients in this study (n=87/103, 85%) perceived that there was a noticeable decrease in the quality of their work and almost 20% (n=19/101) reported being unable to work due to pain. Notably, 69% (n=68/101) of the patients reported that they continue working despite feeling pain, a phenomenon that has been termed “presenteeism” (40). Those patients who admitted missing workdays (n=64, 60%) reported a mean of 2.8 days per month (SD±3.7), equivalent to 33.6 days per year, due to being “unable to perform physical activities”. Yearly, patients missed work an average of 19.3 days (SD±19.3) because of treatments, surgeries, and recovery. These absenteeism rates are higher than those reported for other pain conditions such as headaches, arthritis and back pain (39).

The majority of patients reported a noticeable decrease in the quality of their work due to endometriosis-related and/or coexisting symptoms (n=87/103, 84%), and 1 in 5 reported being temporarily disabled due to symptoms. Forty % of patients (n=36/91) perceived that as a direct consequence of this disease their career growth has been negatively affected due to high rates of absenteeism and/or low performance (n=15), not being promoted (n=8), not receiving merit/excellence bonuses (n=3), missing professional seminars (n=2), and loss of clients (n=1). Three patients reported being “totally incapacitated” and three were dismissed from or quit their jobs due to symptoms.

Logistic regression analysis showed that symptoms significantly predict negative impact on daily life activities, work performance, and social life of patients (all p<0.05 or 0.01). Patients with menstrual pain (OR=22.8, 95%CI: 2.3–226.7), incapacitating pain (OR=35.2, 95%CI: 4.3–274.6), depression (OR=17.2, 95%CI: 2.2–142.9), and abdominal pain (OR=5.2, 95%CI: 2.3–226.7) were more likely to report that their work (both at home and professionally) was affected by endometriosis. Those patients suffering from dyspareunia (OR=39.8, 95%CI: 8.4–188.1) were more likely to report negative effects of disease on their social and sexual lives. Finally, nausea (OR=6.4, 95%CI: 2.2–18.2) and depression (OR=4.3, 95%CI: 1.5–11.9) were significantly associated with changes in appetite. Therefore, menstrual pain, incapacitating pain, abdominal pain and depression were identified as predictors of poor performance at work and home. In addition, incapacitating pain and dyspareunia predict impairments in social and sexual aspects of life.

In drawing conclusions from this study, it is important to consider the low response rate, relatively small sample size, and the fact that the survey was answered predominantly by patients who were substantially affected by the disease (e.g., all respondents were symptomatic; most presented at least eight endometriosis-related and/or co-existing symptoms; most reported suffering from constant, non-menstrual pain; depression rates were as high as 50%). Therefore, the findings of this study may not be representative of all patients with endometriosis, but rather apply only to those with more severe disease. Also of note, the majority of responders were well-educated women. This specific bias has been noted by other studies (29,30). Recall and reporting errors may have also occurred, especially when trying to remember the details of medical events (when did they occur, what were the costs), such as treatments, procedures, and days lost from work (41-43). Finally, the low response rate observed may be explained by cultural issues such as the low awareness of the importance of research, which may explain the poor participation rates in biomedical research studies that have been previously reported in Hispanic minorities (44).

Despite these limitations, this study gathered important patient-reported outcomes (PRO) data supporting the notion that endometriosis-related and/or co-existing symptoms could negatively affect the general wellbeing and work performance of affected women. Efforts to improve delivery of care for patients with endometriosis, leading to a prompt diagnosis and effective management of symptoms and complications, should become a research priority. Such efforts should be driven by PRO research on the economic, emotional, and social costs of endometriosis and that will also provide valuable information about effectiveness of clinical management and therapeutic approaches (45-49). These data are important to help establish endometriosis as an important global public-health problem, irrespective of culture, race or ethnicity.

Acknowledgments

These studies were supported by grants NIH-NICHD #R01 HD050559 and NIH-MBRS #S06-GM08239. The authors thank Bob Ritchie of the RCMI Publications office at the Ponce School of Medicine (Grant #2G12 RR003050) for his assistance in editing this manuscript. Also, the authors thank Job Connection Center, PR, for funding part of this research. Finally, we would like to acknowledge the patients who kindly volunteered to participate in this study and who shared with us their most intimate thoughts, concerns, and personal stories. We value their courage and their determination to take control of their lives.

Financial Support: NIH-NICHD #R01 HD050559 and NIH-MBRS #S06-GM08239.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

CAPSULE

The experience of living with endometriosis may be characterized by physical limitations that affect health, work and daily life.

References

1. Corson SL. Endometriosis: The Enigmatic Disease. 1. Essential Medical Information; USA: 1992.
2. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955:11–22. [PubMed]
3. Ozkan S, Murk W, Arici A. Endometriosis and Infertility: Epidemiology and Evidence-based Treatments. Ann N Y Acad Sci. 2008;1127:92–100. [PubMed]
4. Denny E, Mann CH. A clinical overview of endometriosis: a misunderstood disease. Br J Nurs. 2007;16:1112–1116. [PubMed]
5. Jones G, Jenkinson C, Kennedy S. The impact of endometriosis quality of life: a qualitative analysis. J Psychosom Obstet Gynecol. 2004;25:123–133. [PubMed]
6. Denny E, Khan KS. Systematic reviews of qualitative evidence: what are the experiences of women with endometriosis? J Obstet Gynaecol. 2006;26:501–506. [PubMed]
7. Marques A, Bahamondes L, Aldrighi JM, Petta CA. Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. J Reprod Med. 2004;49:115–120. [PubMed]
8. Cox H, Henderson L, Andersen N, Ski C. Focus group study of endometriosis: struggle, loss and medical merry-go-round. Int J Nurs Pract. 2003;9:2–9. [PubMed]
9. Lemaire GS. More than just menstrual cramps: symptoms and uncertainty among women with endometriosis. J Obstet Gynecol Neonatal Nurs. 2004;33:71–79. [PubMed]
10. Cox H, Henderson L, Wood R, Cagliarini G. Learning to take charge: women’s experiences of living with endometriosis. Complement Ther Nurs Midwifery. 2003;9:62–68. [PubMed]
11. Huntington A, Gilmour JA. A life shaped by pain: women and endometriosis. J Clin Nurs. 2005;14:1124–1132. [PubMed]
12. Denny E. Women’s experience of endometriosis. J Adv Nurs. 2004;46:641–648. [PubMed]
13. Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril. 2006;86:1561–1572. [PubMed]
14. Winkel CA, Scialli AR. Medical and surgical therapies for pain associated with endometriosis. J Women Health Gend Based Med. 2001;10:137–136. [PubMed]
15. Heinrichs WL, Henzl MR. Human issues and medical economics of endometriosis. Three- vs six-month GnRH-agonist therapy. J Reprod Med. 1998;43(3 Suppl):299–308. [PubMed]
16. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87:321–327. [PubMed]
17. Mirkin D, Murphy-Barron C, Iwasaki K. Actuarial analysis of private payer administrative claims data for women with endometriosis. J Manag Care Pharm. 2007;13:262–272. [PubMed]
18. Hummelshoj L, Prentice A, Groothuis P. Update on endometriosis. Women’s Health. 2006;2:53–56. [PubMed]
19. Simoens S, Hummelshoj L, D’Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update. 2007;13:395–404. [PubMed]
20. Zhao SZ, Wong JM, Davis MB, Gersh GE, Johnson KE. The cost of inpatient endometriosis treatment: an analysis based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Am J Manag Care. 1998;4:1127–1134. [PubMed]
21. Gao X, Yeh YC, Outley J, Simon J, Botteman M, Spalding J. Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin. 2006;22:1787–1797. [PubMed]
22. Jones G, Kennedy S, Barnard A, Wong J, Jenkinson C. Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30. Obstet Gynecol. 2001;98:258–264. [PubMed]
23. Jones G, Jenkinson C, Taylor N, Mills A, Kennedy S. Measuring quality of life in women with endometriosis: tests of data quality, score reliability, response rate and scaling assumptions of the Endometriosis Health Profile Questionnaire. Hum Reprod. 2006;21:2686–2693. Epub 2006 Jul 4. [PubMed]
24. Jones G, Jenkinson C, Kennedy S. Development of the Short Form Endometriosis Health Profile Questionnaire: the EHP-5. Qual Life Res. 2004;13:695–704. [PubMed]
25. Scarselli G, Rizzello F, Cammilli F, Ginocchini L, Coccia ME. Diagnosis and treatment of endometriosis. Minerva Ginecol. 2005;57:55–78. [PubMed]
26. Revised American Fertility Society Classification of Endometriosis. Fertil Steril. 1985;43:351–352. [PubMed]
27. Hadfield R, Mardon H, Barlow D, Kennedy S. Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod. 1996;11:878–880. [PubMed]
28. Arruda MS, Petta CA, Abrão MS, Benetti-Pinto CL. Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod. 2003;18:756–759. [PubMed]
29. Ballard K, Lowton K, Wright J. What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril. 2006;86:1296–1301. [PubMed]
30. Greene R, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis. Fertil Steril. 2009;91:32–39. [PubMed]
31. Flores I, Abreu S, Abac S, Fourquet J, Laboy J, Ríos-Bedoya C. Self-reported prevalence of endometriosis and its symptoms among Puerto Rican women. Int J Gynaecol Obstet. 2008;100:257–261. [PMC free article] [PubMed]
32. dos Reis RM, de Sá MF, de Moura MD, Nogueira AA, Ribeiro JU, Ramos ES, Ferriani RA. Familial risk among patients with endometriosis. J Assist Reprod Genet. 1999;16:500–503. [PMC free article] [PubMed]
33. Kashima K, Ishimaru T, Okamura H, Suginami H, Ikuma K, Murakami T, Iwashita M, Tanaka K. Familial risk among Japanese patients with endometriosis. Int J Gynaecol Obstet. 2004;84:61–64. [PubMed]
34. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod. 2002;17:2715–2724. [PubMed]
35. Peveler R, Edwards J, Daddow J, Thomas E. Psychosocial factors and chronic pelvic pain: a comparison of women with endometriosis and with unexplained pain. J Psychosom Res. 1996;40:305–315. [PubMed]
36. Low WY, Edelmann RJ, Sutton C. A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins. J Psychosom Res. 1993;37:111–116. [PubMed]
37. Lerner D, Mirza F, Chang H, Renzulli K, Perch K, Chelmow D. Impaired Work Performance Among Women With Symptomatic Uterine Fibroids. J Occup Environ Med. 2008;50:1149–1157. [PubMed]
38. Bejarano V, Quinn M, Conaghan PG, Reece R, Keenan AM, Walker D, et al. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008;59:1467–1474. [PubMed]
39. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443–2454. [PubMed]
40. Hansen CD, Andersen JH. Going ill to work--what personal circumstances, attitudes and work-related factors are associated with sickness presenteeism? Soc Sci Med. 2008;67:956–964. Epub 2008 Jun 19. [PubMed]
41. Boyer GS, Templin DW, Goring WP, Cornoni-Huntley JC, Everett DF, Lawrence RC, Heyse SP, Bowler A. Discrepancies between patient recall and the medical record. Potential impact on diagnosis and clinical assessment of chronic disease. Arch Intern Med. 1995;155:1868–1872. [PubMed]
42. Warnecke RB, Sudman S, Johnson TP, O’Rourke D, Davis AM, Jobe JB. Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol. 1997;146:982–992. [PubMed]
43. Hook EB, Regal RR. Validity of methods for model selection, weighting for model uncertainty, and small sample adjustment in capture-recapture estimation. Am J Epidemiol. 1997;145:1138–1144. [PubMed]
44. Katz RV, Wang MQ, Green BL, Kressin NR, Claudio C, Russell SL, Sommervil C. Participation in biomedical research studies and cancer screenings: perceptions of risks to minorities compared with whites. Cancer Control. 2008;15:344–351. [PMC free article] [PubMed]
45. Denny E, Mann CH. Endometriosis and the primary care consultation. Eur J Obstet Gynecol Reprod Biol. 2008;139:111–115. [PubMed]
46. Pugsley Z, Ballard K. Management of endometriosis in general practice: the pathway to diagnosis. Br J Gen Pract. 2007;57:470–476. [PMC free article] [PubMed]
47. Matsuzaki S, Canis M, Pouly JL, Rabischong B, Botchorishvili R, Mage G. Relationship between delay of surgical diagnosis and severity of disease in patients with symptomatic deep infiltrating endometriosis. Fertil Steril. 2006;86:1314–1316. [PubMed]
48. Fuchs F, Raynal P, Salama S, Guillot E, Le Tohic A, Chis C, Panel P. Reproductive outcome after laparoscopic treatment of endometriosis in an infertile population. J Gynecol Obstet Biol Reprod. 2007;36:354–359. [PubMed]
49. O’Keefe-McCarthy S. Women’s experiences of cardiac pain: a review of the literature. Can J Cardiovasc Nurs. 2008;18:18–25. [PubMed]